Eunice Y Lee Selected Research

Type II Keratins (Type II Keratin)

10/2022

Whole exome sequencing in Alopecia Areata identifies rare variants in KRT82.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eunice Y Lee Research Topics

Disease

10	Neoplasms (Cancer) 01/2019 - 12/2002
4	Asthma (Bronchial Asthma) 01/2021 - 01/2017
3	Fatigue 01/2018 - 12/2017
2	Alopecia Areata 10/2022 - 05/2022
2	Anemia 01/2018 - 12/2017
2	Nausea 01/2018 - 12/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 12/2017
2	Constipation 01/2018 - 12/2017
2	Thrombocytopenia (Thrombopenia) 01/2018 - 12/2017
2	Vomiting 01/2018 - 12/2017
2	Diarrhea 01/2018 - 12/2017
2	Dyspnea (Shortness of Breath) 01/2018 - 12/2017
2	Exanthema (Rash) 01/2018 - 01/2018
2	Medulloblastoma 05/2010 - 11/2008
1	COVID-19 05/2022
1	Infections 05/2022
1	Inflammation (Inflammations) 01/2019
1	Neutropenia 01/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2018
1	Glioma (Gliomas) 01/2018
1	Headache (Headaches) 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018
1	Leukemia 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Nasopharyngitis 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Mucositis 01/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Abdominal Pain (Pain, Abdominal) 12/2017
1	Dysgeusia (Parageusia) 12/2017
1	Retinoblastoma (Glioblastoma, Retinal) 01/2010

Drug/Important Bio-Agent (IBA)

3	E2F Transcription FactorsIBA 01/2010 - 12/2002
3	Retinoblastoma ProteinIBA 09/2008 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2018
2	PlatinumIBA 01/2018 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 05/2010
1	Type II Keratins (Type II Keratin)IBA 10/2022
1	tofacitinibIBA 05/2022
1	Bronchodilator Agents (Bronchodilators)IBA 01/2021
1	Stem Cell FactorIBA 01/2020
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019
1	Air Pollutants (Pollutants, Air)IBA 01/2019
1	OzoneIBA 01/2019
1	SteroidsIBA 01/2019
1	Particulate MatterIBA 01/2019
1	niraparibIBA 01/2018
1	trametinibIBA 01/2018
1	dabrafenibIBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	ForminsIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	osimertinibIBA 01/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	ZincIBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	rucaparibIBA 12/2017
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2017
1	Complement System Proteins (Complement)IBA 10/2011
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2010
1	Insulin-Like PeptidesIBA 11/2008

Therapy/Procedure

5	Therapeutics 05/2022 - 05/2010
3	Drug Therapy (Chemotherapy) 01/2018 - 12/2017
1	Precision Medicine 01/2020